Corticosteroid Eye Drops for Scleritis
Corticosteroid eye drops alone are insufficient for most cases of scleritis and should only be considered for mild, non-necrotizing anterior scleritis—the majority of scleritis cases require systemic corticosteroids or immunosuppressive therapy.
Treatment Algorithm Based on Scleritis Severity
Mild to Moderate Non-Necrotizing Anterior Scleritis
- Topical corticosteroid drops may be attempted as initial therapy in mild cases 1
- However, only 16.7% of scleritis patients can be controlled with topical therapy alone—the vast majority require escalation 2
- If no improvement within 1-2 weeks, immediately escalate to systemic therapy
Moderate to Severe or Any Necrotizing/Posterior Scleritis
- Systemic corticosteroids are the mainstay of treatment 1, 3
- 30.4% require oral NSAIDs, 31.9% require oral prednisone, and 26.1% require systemic immunosuppressive drugs 2
- Necrotizing and posterior scleritis require systemic therapy in 90-100% of cases 2
Why Topical Drops Usually Fail
The evidence is clear that scleritis differs fundamentally from superficial eye inflammation:
- 58.8% of scleritis patients develop ocular complications (versus only 13.5% with episcleritis) 2
- 15.9% experience vision loss 2
- The deep scleral inflammation requires systemic drug levels that topical drops cannot achieve
- Scleritis is frequently associated with systemic autoimmune disease (rheumatoid arthritis most common), requiring systemic immunosuppression 1, 4
Critical Pitfall to Avoid
Do not waste time with prolonged trials of topical corticosteroids in anything beyond the mildest cases. Delayed systemic treatment increases the risk of:
- Scleral thinning and perforation
- Peripheral ulcerative keratitis
- Anterior uveitis
- Permanent vision loss
Steroid-Sparing Options
For steroid-dependent or refractory cases:
- Methotrexate shows significant efficacy for inflammation control 3
- Other immunosuppressives (azathioprine, mycophenolate) are alternatives 4, 2
- Sub-tenon triamcinolone injection can be effective for localized disease 5
- Biologic agents for conventional therapy failures 1, 6
The bottom line: While topical corticosteroid drops exist and can be tried in mild cases, scleritis is fundamentally a systemic inflammatory disease requiring systemic treatment in the vast majority of patients.